Analysts See $0.24 EPS for Neogen Corporation (NEOG)

February 27, 2018 - By Henry Gaston

 Analysts See $0.24 EPS for Neogen Corporation (NEOG)
Investors sentiment increased to 1.48 in 2017 Q3. Its up 0.43, from 1.05 in 2017Q2. It increased, as 10 investors sold Neogen Corporation shares while 53 reduced holdings. 31 funds opened positions while 62 raised stakes. 33.03 million shares or 0.90% more from 32.73 million shares in 2017Q2 were reported.
8,321 were reported by Piedmont Inv Advsr Lc. 22,014 are owned by Sterling Mngmt Ltd Liability Com. Numeric Llc holds 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG) for 5,000 shares. Azimuth Cap Mgmt Llc reported 11,508 shares or 0.07% of all its holdings. Envestnet Asset Mgmt Inc reported 0.01% in Neogen Corporation (NASDAQ:NEOG). Moreover, Ahl Prtn Ltd Liability Partnership has 0.02% invested in Neogen Corporation (NASDAQ:NEOG) for 14,398 shares. Financial Bank Of Montreal Can invested 0% in Neogen Corporation (NASDAQ:NEOG). Oppenheimer Asset Mgmt holds 27,228 shares or 0.05% of its portfolio. Great Lakes Advsrs Ltd Llc reported 0.08% in Neogen Corporation (NASDAQ:NEOG). Tompkins invested in 0.01% or 305 shares. Neuberger Berman Grp Ltd Co has invested 0.05% in Neogen Corporation (NASDAQ:NEOG). Bnp Paribas Arbitrage holds 0% in Neogen Corporation (NASDAQ:NEOG) or 20,008 shares. Wesbanco Commercial Bank holds 23,000 shares. Dimensional Fund Advsrs Ltd Partnership holds 563,814 shares or 0.02% of its portfolio. First Republic Investment reported 0% stake.

Since September 5, 2017, it had 0 insider purchases, and 19 insider sales for $15.27 million activity. Another trade for 6,000 shares valued at $358,320 was sold by PAPESH G BRUCE. $176,676 worth of Neogen Corporation (NASDAQ:NEOG) shares were sold by Quinlan Steven J.. BRADLEY EDWARD had sold 7,000 shares worth $417,223. $421,833 worth of Neogen Corporation (NASDAQ:NEOG) shares were sold by MORRICAL TERRI A.

Analysts expect Neogen Corporation (NASDAQ:NEOG) to report $0.24 EPS on March, 20.They anticipate $0.04 EPS change or 20.00 % from last quarter’s $0.2 EPS. NEOG’s profit would be $12.37M giving it 62.51 P/E if the $0.24 EPS is correct. After having $0.33 EPS previously, Neogen Corporation’s analysts see -27.27 % EPS growth. The stock decreased 0.17% or $0.1 during the last trading session, reaching $60.01. About 189,119 shares traded or 18.66% up from the average. Neogen Corporation (NASDAQ:NEOG) has risen 27.20% since February 27, 2017 and is uptrending. It has outperformed by 10.50% the S&P500.

Neogen Corporation (NASDAQ:NEOG) Ratings Coverage

Among 4 analysts covering Neogen (NASDAQ:NEOG), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Neogen had 6 analyst reports since August 26, 2015 according to SRatingsIntel. Craig Hallum downgraded the shares of NEOG in report on Tuesday, December 22 to “Hold” rating. The stock has “Buy” rating by Zacks on Wednesday, August 26. The rating was downgraded by Zacks to “Hold” on Tuesday, September 22. Roth Capital maintained Neogen Corporation (NASDAQ:NEOG) rating on Thursday, January 4. Roth Capital has “Hold” rating and $62.0 target.

Neogen Corporation, together with its subsidiaries, develops, makes, and markets various products for food and animal safety worldwide. The company has market cap of $3.09 billion. It operates through two divisions, Food Safety and Animal Safety. It has a 59.71 P/E ratio. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Another recent and important Neogen Corporation (NASDAQ:NEOG) news was published by which published an article titled: “Neogen releases easiest dairy antibiotic tests” on February 01, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: